Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Peptides), Disease Indication (Infectious Diseases, Oncology), Manufacturing Type (In-House Manufacturing, Contract Manufacturing) – Global Outlook & Forecast 2023-2031
Format: PDF | Report ID: GR - 472976 | Published On:15 May, 2021 | Pages: 100-120
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
